Cargando…
Enhanced efficacy in drug-resistant cancer cells through synergistic nanoparticle mediated delivery of cisplatin and decitabine
There are several limitations with monodrug cancer therapy, including poor bioavailability, rapid clearance and drug resistance. Combination therapy addresses these by exploiting synergism between different drugs against cancer cells. In particular, the combination of epigenetic therapies with conve...
Autores principales: | Parhizkar, M., Reardon, P. J. T., Harker, A. H., Browning, R. J., Stride, E., Pedley, R. B., Knowles, J. C., Edirisinghe, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419023/ https://www.ncbi.nlm.nih.gov/pubmed/36133040 http://dx.doi.org/10.1039/c9na00684b |
Ejemplares similares
-
Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment
por: Reardon, Philip JT, et al.
Publicado: (2017) -
Electrosprayed microparticles for intestinal delivery of prednisolone
por: Shams, T., et al.
Publicado: (2018) -
Copolymer Composition and Nanoparticle Configuration Enhance in vitro Drug Release Behavior of Poorly Water-soluble Progesterone for Oral Formulations
por: Zhang, Yue, et al.
Publicado: (2020) -
Decitabine and Cisplatin are Synergistic to Exert Anti-Tumor Effect on Gastric Cancer via Inducing Sox2 DNA Demethylation
por: Zhu, Zhipeng, et al.
Publicado: (2021) -
DNA–affibody nanoparticle delivery system for cisplatin-based breast cancer chemotherapy
por: Zhang, Chao, et al.
Publicado: (2019)